Parent, teacher, child. A trilateral approach to attention deficit disorder
- PMID: 2801667
Parent, teacher, child. A trilateral approach to attention deficit disorder
Abstract
We compared the effectiveness of three instruments in initially diagnosing and monitoring children with attention-deficit disorder with and without hyperactivity (ADD/H). Twenty-one children clinically assessed as having ADD/H and meeting criteria of the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, were examined initially and after treatment with methylphenidate hydrochloride and placebo. The following instruments were used: the ADD-H Comprehensive Teacher Rating Scale, the Connors' Parent Rating Scale-Revised, and the Gordon Diagnostic System. The ADD-H Comprehensive Teacher Rating Scale initially classified 67% of the children as having ADD/H and 14% as borderline. The Connors' Parent Rating Scale-Revised identified 71% as having ADD/H, while the Gordon Diagnostic System assessed 52% as having ADD/H and 29% as borderline. With methylphenidate treatment, the mean scores on the ADD-H Comprehensive Teacher Rating Scale displayed an increase in attention span and a decrease in hyperactivity, the Connors' Parent Rating Scale-Revised showed a significant decrease in ADD/H behavior, and the Gordon Diagnostic System mean scores indicated no significant change.
Similar articles
-
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953. Pediatrics. 2005. PMID: 15629972
-
Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate.Pediatrics. 1991 Apr;87(4):519-31. Pediatrics. 1991. PMID: 2011430 Clinical Trial.
-
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844. Pediatrics. 2004. PMID: 15520087
-
A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.Pediatrics. 2008 Jan;121(1):e73-84. doi: 10.1542/peds.2006-3695. Pediatrics. 2008. PMID: 18166547 Clinical Trial.
-
Methylphenidate dosing: twice daily versus three times daily.Pediatrics. 1996 Oct;98(4 Pt 1):748-56. Pediatrics. 1996. PMID: 8885956 Clinical Trial.
Cited by
-
Healthcare use, social burden and costs of children with and without ADHD in Flanders, Belgium.Clin Drug Investig. 2006;26(2):75-90. doi: 10.2165/00044011-200626020-00003. Clin Drug Investig. 2006. PMID: 17163238
-
ADHD: Is Objective Diagnosis Possible?Psychiatry (Edgmont). 2005 Nov;2(11):44-53. Psychiatry (Edgmont). 2005. PMID: 21120096 Free PMC article.
-
SPECT Functional Neuroimaging Distinguishes Adult Attention Deficit Hyperactivity Disorder From Healthy Controls in Big Data Imaging Cohorts.Front Psychiatry. 2021 Nov 24;12:725788. doi: 10.3389/fpsyt.2021.725788. eCollection 2021. Front Psychiatry. 2021. PMID: 34899414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical